Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.
Domini International Opportunities Inv RISEX
- NAV / 1-Day Return 11.37 / +0.35 %
- Total Assets 24.5 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.400%
- Distribution Fee Level High
- Share Class Type No Load
- Category Foreign Large Growth
- Investment Style Large Growth
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 0.87%
- Turnover 18%
USD | NAV as of Oct 04, 2024 | 1-Day Return as of Oct 04, 2024, 10:12 PM GMT+0
Morningstar’s Analysis RISEX
Will RISEX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 29.2
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novo Nordisk A/S Class B | 5.88 | 1.4 Mil | Healthcare |
ASML Holding NV | 4.85 | 1.1 Mil | Technology |
AstraZeneca PLC | 2.83 | 668,910 | Healthcare |
Novartis AG Registered Shares | 2.79 | 658,953 | Healthcare |
Toyota Motor Corp | 2.69 | 633,928 | Consumer Cyclical |
SAP SE | 2.52 | 593,989 | Technology |
Linde PLC | 2.51 | 593,271 | Basic Materials |
Siemens AG | 1.79 | 423,063 | Industrials |
Commonwealth Bank of Australia | 1.72 | 405,598 | Financial Services |
Unilever PLC | 1.61 | 380,424 | Consumer Defensive |